Morning Movers 06/19: (NEI) (VRNG) (GALE) Higher; (SSN) (JCP) Lower
Tweet Send to a Friend
Get Alerts NEI Hot Sheet
Trade NEI Now!
NEI (Nasdaq: NEI) 81.7% HIGHER; announced today that it has signed a definitive merger agreement with UNICOM Systems, Inc. and a new UNICOM subsidiary under which UNICOM, will acquire NEI for $1.45 per common share in cash.
Samson Oil & Gas Limited (AMEX: SSN) 23.9% LOWER; provides operational advice on its Hawk Springs and Roosevelt Projects. Click here to see the updates.
Vringo (AMEX: VRNG) 18.2% HIGHER; stock continuing over the $4 level today following yesterday's news of a memorandum opinion and order issued in the proposed merger partner's patent infringement lawsuit.
Galena Biopharma (Nasdaq: GALE) 13.8% HIGHER; continuing a late-day move higher yesterday. The stock closed up 7.5 percent. Shares are over $1.40 today.
Oclaro (Nasdaq: OCLR) 13.4% HIGHER; breaking out after bumping up against the $2.50 since early June. Shares are over $2.75 today, but have not been able to hold above $3.
Opnext (Nasdaq: OPXT) 13.2% HIGHER; it seems a number of stocks in the optical sector are trending higher today.
L&L Energy (Nasdaq: LLEN) 13.1% HIGHER; continuing higher (over the $2 level) following an 11.5 percent rise yesterday amid an MoU to acquire the Lashu Mine in Guizhou.
Eagle Bulk Shipping (Nasdaq: EGLE) 12.5% HIGHER; pushing over resistance at $3 after breaking above the 50- and 200-day simple moving averages just after the open. Volume is very heavy today.
Zalicus Inc. (NASDAQ: ZLCS) 11.8% HIGHER; today announced that it is has successfully completed a Phase 1 single ascending dose (SAD) clinical study with Z944, its novel, oral, T-type calcium channel blocker. The study results indicate that Z944 was generally well-tolerated and a maximum tolerated dose was achieved. Z944 will advance into a Phase 1 multiple ascending dose (MAD) study in the third quarter of 2012. Assuming Z944 successfully completes the MAD study, Z944 could enter Phase 2 clinical development in the first quarter of 2013.
National Bank of Greece (NYSE: NBG) 11.6% HIGHER; shares are up nearly 60 percent since June 12th as things in Greece seem to be cooling down.
J. C. Penney Company, Inc. (NYSE: JCP) 10.3% LOWER; today announced that Michael Francis will be leaving the Company, effective today. Chief Executive Officer Ron Johnson will assume direct responsibility and oversight of the company's marketing and merchandising functions.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Samson Oil & Gas Limited (AMEX: SSN) 23.9% LOWER; provides operational advice on its Hawk Springs and Roosevelt Projects. Click here to see the updates.
Vringo (AMEX: VRNG) 18.2% HIGHER; stock continuing over the $4 level today following yesterday's news of a memorandum opinion and order issued in the proposed merger partner's patent infringement lawsuit.
Galena Biopharma (Nasdaq: GALE) 13.8% HIGHER; continuing a late-day move higher yesterday. The stock closed up 7.5 percent. Shares are over $1.40 today.
Oclaro (Nasdaq: OCLR) 13.4% HIGHER; breaking out after bumping up against the $2.50 since early June. Shares are over $2.75 today, but have not been able to hold above $3.
Opnext (Nasdaq: OPXT) 13.2% HIGHER; it seems a number of stocks in the optical sector are trending higher today.
L&L Energy (Nasdaq: LLEN) 13.1% HIGHER; continuing higher (over the $2 level) following an 11.5 percent rise yesterday amid an MoU to acquire the Lashu Mine in Guizhou.
Eagle Bulk Shipping (Nasdaq: EGLE) 12.5% HIGHER; pushing over resistance at $3 after breaking above the 50- and 200-day simple moving averages just after the open. Volume is very heavy today.
Zalicus Inc. (NASDAQ: ZLCS) 11.8% HIGHER; today announced that it is has successfully completed a Phase 1 single ascending dose (SAD) clinical study with Z944, its novel, oral, T-type calcium channel blocker. The study results indicate that Z944 was generally well-tolerated and a maximum tolerated dose was achieved. Z944 will advance into a Phase 1 multiple ascending dose (MAD) study in the third quarter of 2012. Assuming Z944 successfully completes the MAD study, Z944 could enter Phase 2 clinical development in the first quarter of 2013.
National Bank of Greece (NYSE: NBG) 11.6% HIGHER; shares are up nearly 60 percent since June 12th as things in Greece seem to be cooling down.
J. C. Penney Company, Inc. (NYSE: JCP) 10.3% LOWER; today announced that Michael Francis will be leaving the Company, effective today. Chief Executive Officer Ron Johnson will assume direct responsibility and oversight of the company's marketing and merchandising functions.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- 50-Day SMA Crossers 05/20: (ELN) (ACI) (AAPL) Above; (MRK) (TLAB) (CLSN) Below
- Trading Radar for 05/22: Hewlett-Packard (HPQ), Target (TGT), Toll Brothers (TOL), Guess? (GES) Report
- Notable Mergers and Acquisitions of the Day 05/21: (CLWR)/(S) (PM)
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Morning Movers, Oclaro/Opnext
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
